Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 25, 2000

View Archived Issues

Failure Of Genital Warts Product Sends Cantab's Stock Tumbling

OECD, WHO Call For International Xenotransplantation Surveillance

Renovo Raises #8M In 1st Round For Wound-Healing Treatments

Selfish DNA In Rickettsia Species Generates New Protein Sequences

Other News To Note

Correction (Article Updated on Database)

Neurotech Continues To Build Intellectual Property Portfolio

4SC Joins EU Consortium To Battle Malaria Complications

Xenova's XR9576 Continues Positive Showing In Phase II

Prodi Renews Call For Ethics In Science And Technology

Environmentalists Seek Ban On Novartis Corn In France

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.